Only For Children Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Paris France (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2011
NCT01434225
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

azithromycin (zithromax) (1 trial)

Drugs in Phase 2 Trials (1)

bumetanide (bumex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchopulmonary Dysplasia (Phase 3)

Seizures (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2